{"url_path":"/sec/goco/8-k/2026-07-21/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 Unregistered Sales of Equity Securities.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-21","source_url":"https://www.sec.gov/Archives/edgar/data/1808220/0001628280-26-049063-index.html","accession_number":"0001628280-26-049063","cik":"0001808220","ticker":"GOCO","issuer_name":"GoHealth, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1808220/0001628280-26-049063-index.html","primary_entity_key":"0001808220","primary_entity_name":"GoHealth, Inc."},"word_count":100,"has_tables":true,"body_markdown":"Item 3.02 Unregistered Sales of Equity Securities.\n\nAs disclosed above, on the Effective Date, the Company converted into a limited liability company, New GoHealth, LLC, and in connection therewith, adopted a new Limited Liability Company Agreement and issued 100% of the New Common Interests to the holders of Allowed First Lien Claims on a pro rata basis. The issuance of the New Common Interests was exempt from registration under the Securities Act of 1933, as amended, pursuant to section 1145 of the Bankruptcy Code (which generally exempts from such registration requirements the issuance of securities under a plan of reorganization)."}